/PRPO

PRPO Stock - Precipio, Inc.

Q: What is the analyst price target for PRPO?

Analyst price target information is not currently available for PRPO.

Q: What is PRPO's market cap?

Market capitalization information is not currently available for PRPO.

Healthcare|Medical - Diagnostics & Research|NASDAQ

$22.19-4.31%

$1.00 (-4.31%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $24.41

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for PRPO

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.09

52W High$28.50

52W Low$3.90

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$15.96M	$15.20M	$9.41M	$8.85M	$6.09M
Gross Profit	$7.56M	$6.02M	$2.51M	$2.39M	$1.15M
Gross Margin	47.3%	39.6%	26.7%	27.0%	18.9%
Operating Income	$-4,216,000	$-7,620,000	$-12,797,000	$-9,613,000	$-9,146,000
Net Income	$-4,290,000	$-5,853,000	$-12,203,000	$-8,550,000	$-10,625,000
Net Margin	-26.9%	-38.5%	-129.7%	-96.6%	-174.4%
EPS	$-2.93	$-4.51	$-10.73	$-8.10	$-14.84

Company Overview

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.

Visit Website

Earnings History & Surprises

PRPO

Beat Rate

15%

Last 13 quarters

Avg Surprise

-789.4%

EPS vs Estimate

Beats / Misses

2/10

1 met exactly

Latest EPS

$-0.05

Q4 2025

EPS Surprise History

Q1 24

+55.9%

$-0.41vs$-0.93

Q2 24

-57.0%

$-1.46vs$-0.93

Q3 24

-1560.0%

$-0.83vs$-0.05

Q4 24

-205.0%

$-0.42vs$0.40

Q1 25

-131.1%

$-0.23vs$0.74

Q2 25

No data

Q3 25

No data

Q4 25

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 12, 2026	—	—	—	—
Q1 2026	Feb 23, 2026	—	—	—	—
Q4 2025	Nov 14, 2025	—	$-0.05	—	—
Q3 2025	Aug 13, 2025	—	$0.05	—	—
Q2 2025	May 14, 2025	—	$-0.59	—	—
Q1 2025	Mar 27, 2025	$0.74	$-0.23	-131.1%	✗ MISS
Q4 2024	Nov 6, 2024	$0.40	$-0.42	-205.0%	✗ MISS
Q3 2024	Aug 13, 2024	$-0.05	$-0.83	-1560.0%	✗ MISS
Q2 2024	May 14, 2024	$-0.93	$-1.46	-57.0%	✗ MISS
Q1 2024	Mar 29, 2024	$-0.93	$-0.41	+55.9%	✓ BEAT
Q4 2023	Nov 13, 2023	$-1.21	$-1.04	+14.0%	✓ BEAT
Q3 2023	Aug 11, 2023	$-0.10	$-1.80	-1700.0%	✗ MISS
Q2 2023	May 12, 2023	$-0.13	$-2.60	-1900.0%	✗ MISS
Q1 2023	Mar 30, 2023	$0.14	$-2.00	-1528.6%	✗ MISS
Q4 2022	Nov 10, 2022	$-0.80	$-2.80	-250.0%	✗ MISS
Q3 2022	Aug 11, 2022	$-1.80	$-1.80	0.0%	= MET
Q2 2022	May 11, 2022	$-1.00	$-4.00	-300.0%	✗ MISS
Q1 2022	Mar 30, 2022	—	$-1.80	—	—
Q4 2021	Nov 12, 2021	—	$-1.60	—	—
Q3 2021	Aug 12, 2021	$-0.10	$-2.80	-2700.0%	✗ MISS

Frequently Asked Questions about PRPO

What is PRPO's current stock price?

Precipio, Inc. (PRPO) is currently trading at $22.19 per share. The stock has moved -4.31% today.

What is the analyst price target for PRPO?

No analyst price targets are currently available for this stock.

What sector is Precipio, Inc. in?

Precipio, Inc. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the NASDAQ exchange.

What is PRPO's market cap?

Precipio, Inc. has a market capitalization of $0.03 billion, making it a small-cap company.

Does PRPO pay dividends?

No, Precipio, Inc. does not currently pay a dividend to shareholders.